Lessons from nature: "Pathogen-Mimetic" systems for mucosal Nano-medicines

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Mucosal surfaces establish an interface with external environments that provide a protective barrier with the capacity to selectively absorb and secrete materials important for homeostasis of the organism. In man, mucosal surfaces such as those in the gastrointestinal tract, respiratory tree and genitourinary system also represent significant barrier to the successful administration of certain pharmaceutical agents and the delivery of newly designed nano-scale therapeutic systems. This review examines morphological, physiological and biochemical aspects of these mucosal barriers and presents currently understood mechanisms used by a variety of virulence factors used by pathogenic bacteria to overcome various aspects of these mucosal barriers. Such information emphasizes the impediments that biologically active materials must overcome for absorption across these mucosal surfaces and provides a template for strategies to overcome these barriers for the successful delivery of nano-scale bioactive materials. also known as nanomedicines.
Original languageEnglish
Pages (from-to)172-192
Number of pages21
JournalAdvanced Drug Delivery Reviews
Volume61
Issue number2
DOIs
Publication statusPublished - 27 Feb 2009

Fingerprint

Nanomedicine
Urogenital System
Virulence Factors
Respiratory System
Gastrointestinal Tract
Homeostasis
Medicine
Bacteria
Pharmaceutical Preparations
Therapeutics

Keywords

  • Delivery
  • Transcytosis
  • Bacterial toxin
  • Protein therapeutics

Cite this

Lessons from nature: "Pathogen-Mimetic" systems for mucosal Nano-medicines. / Mrsny, Randall J.

In: Advanced Drug Delivery Reviews, Vol. 61, No. 2, 27.02.2009, p. 172-192.

Research output: Contribution to journalArticle

@article{6bc6fe64483145788a91929e267272d5,
title = "Lessons from nature: {"}Pathogen-Mimetic{"} systems for mucosal Nano-medicines",
abstract = "Mucosal surfaces establish an interface with external environments that provide a protective barrier with the capacity to selectively absorb and secrete materials important for homeostasis of the organism. In man, mucosal surfaces such as those in the gastrointestinal tract, respiratory tree and genitourinary system also represent significant barrier to the successful administration of certain pharmaceutical agents and the delivery of newly designed nano-scale therapeutic systems. This review examines morphological, physiological and biochemical aspects of these mucosal barriers and presents currently understood mechanisms used by a variety of virulence factors used by pathogenic bacteria to overcome various aspects of these mucosal barriers. Such information emphasizes the impediments that biologically active materials must overcome for absorption across these mucosal surfaces and provides a template for strategies to overcome these barriers for the successful delivery of nano-scale bioactive materials. also known as nanomedicines.",
keywords = "Delivery, Transcytosis, Bacterial toxin, Protein therapeutics",
author = "Mrsny, {Randall J}",
year = "2009",
month = "2",
day = "27",
doi = "10.1016/j.addr.2008.09.009",
language = "English",
volume = "61",
pages = "172--192",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Lessons from nature: "Pathogen-Mimetic" systems for mucosal Nano-medicines

AU - Mrsny, Randall J

PY - 2009/2/27

Y1 - 2009/2/27

N2 - Mucosal surfaces establish an interface with external environments that provide a protective barrier with the capacity to selectively absorb and secrete materials important for homeostasis of the organism. In man, mucosal surfaces such as those in the gastrointestinal tract, respiratory tree and genitourinary system also represent significant barrier to the successful administration of certain pharmaceutical agents and the delivery of newly designed nano-scale therapeutic systems. This review examines morphological, physiological and biochemical aspects of these mucosal barriers and presents currently understood mechanisms used by a variety of virulence factors used by pathogenic bacteria to overcome various aspects of these mucosal barriers. Such information emphasizes the impediments that biologically active materials must overcome for absorption across these mucosal surfaces and provides a template for strategies to overcome these barriers for the successful delivery of nano-scale bioactive materials. also known as nanomedicines.

AB - Mucosal surfaces establish an interface with external environments that provide a protective barrier with the capacity to selectively absorb and secrete materials important for homeostasis of the organism. In man, mucosal surfaces such as those in the gastrointestinal tract, respiratory tree and genitourinary system also represent significant barrier to the successful administration of certain pharmaceutical agents and the delivery of newly designed nano-scale therapeutic systems. This review examines morphological, physiological and biochemical aspects of these mucosal barriers and presents currently understood mechanisms used by a variety of virulence factors used by pathogenic bacteria to overcome various aspects of these mucosal barriers. Such information emphasizes the impediments that biologically active materials must overcome for absorption across these mucosal surfaces and provides a template for strategies to overcome these barriers for the successful delivery of nano-scale bioactive materials. also known as nanomedicines.

KW - Delivery

KW - Transcytosis

KW - Bacterial toxin

KW - Protein therapeutics

UR - http://www.scopus.com/inward/record.url?scp=60149088354&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1016/j.addr.2008.09.009

U2 - 10.1016/j.addr.2008.09.009

DO - 10.1016/j.addr.2008.09.009

M3 - Article

VL - 61

SP - 172

EP - 192

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 2

ER -